NCT04269928View on ClinicalTrials.gov

Effects of Adrenal Artery Ablation and Adrenalectomy in Patients With Primary Aldosteronism

CompletedOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

January 19, 2016

Primary Completion Date

December 30, 2019

Study Completion Date

June 1, 2021

Conditions
Primary AldosteronismHypertension
Interventions
PROCEDURE

Endovascular chemical ablation of adrenal gland

Patients in this group will be treated with ablation of adrenal gland by endovascular injection of dehydrated alcohol

Trial Locations (1)

400042

The third hospital affiliated to the Army Medical University, Chongqing

All Listed Sponsors
lead

Third Military Medical University

OTHER

NCT04269928 - Effects of Adrenal Artery Ablation and Adrenalectomy in Patients With Primary Aldosteronism | Biotech Hunter | Biotech Hunter